Serial Number
79453338
Owner
Biodelphis Therapeutics SAAttorney
Jaron BentleyFiling Date
Mar 27, 2026
BIODELPHIS THERAPEUTICS Trademark
Serial Number: 79453338
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 40 - Treatment & Processing
Treatment of materials
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Correspondence Address
Jaron Bentley Daymark Legal
2701 Cambridge Court
Auburn Hills, MI 48326
United States
Trademark Details
Filing Date
March 27, 2026
Registration Date
Not Registered
Goods & Services
Retail or wholesale services for pharmaceutical, biotechnological and veterinary preparations as well as for medical supplies; all of the foregoing, with the exception of retail, wholesale or consulting services concerning diagnostic medical devices, genetic testing reagents or equipment intended for neurological research or diagnosis
Processing and manufacturing of biochemical and pharmaceutical products for third parties and related consulting services; custom manufacturing of pharmaceutical products to order and according to a client's specifications; all of the foregoing, with the exception of services involving DNA sequencing, gene cloning, genetic modification of cells or nanotechnological processes intended for administering therapeutic agents
Research and development for the pharmaceutical industry; research and development in the field of biotechnology; biotechnology research; research in biotechnology; biomedical research services; pharmaceutical research and development services; medical research services; scientific research services for medical purposes; scientific and technological services, as well as related research and development services; all of the above, excluding medical or clinical research in the field of genetic or neurological diseases, as well as services related to genetic engineering, DNA manipulation, or drug delivery using nanotechnology
Pharmaceutical preparations, namely antibody-peptide inhibitor conjugates intended for use in oncology as well as for the treatment of osteoporosis and autoimmune diseases; Dietary supplements for humans; all of the foregoing, excluding pharmaceutical or biotechnological preparations intended for genetic or neurological diagnosis or treatment, or involving genetic engineering, DNA manipulation, or drug delivery systems based on nanotechnology